MARCKS and Miyoshi myopathy: Specifically, we demonstrated a dose-dependent cytotoxic effect of the PSD peptidomimetic MPS in drug-resistant MM cells in vitro and in vivo, caused by the targeted inhibition of MARCKS phosphorylation [132].